|
1
|
Lee JY, Cho KB, Kim ES, Park KS, Lee YJ,
Lee YS, Jang BK, Chung WJ and Hwang JS: Risk factors for local
recurrence after en bloc endoscopic submucosal dissection for early
gastric cancer. World J Gastrointest Endosc. 8:330–337. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pirogov SS, Sokolov VV, Karpova ES, Pavlov
PV, Volchenko NN and Kaprin AD: Early gastric cancer and
precancerous conditions diagnostics with confocal laser
endomicroscopy. Eksp Klin Gastroenterol. 3:18–24. 2014.(In
Russian).
|
|
3
|
Jianhui C, Yulong H, Chuangqi C, Kaiming
W, Xinhua Z and Shirong C: Comparison of clinicopathological
features of gastric carcinoma, between 2 times periods, at a single
institute in China. J Cancer Res Ther. 11:874–881. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoteya S, Iizuka T, Kikuchi D, Ogawa O,
Mitani T, Matsui A, Furuhata T, Yamashita S, Yamada A and Kaise M:
Clinicopathological outcomes of patients with early gastric cancer
after non-curative endoscopic submucosal dissection. Digestion.
93:pp. 53–58. 2016; View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu Z, Yang L, Yu J, Lu M, Zhang X, Li J,
Zhou J, Wang X, Gong J, Gao J, et al: Change of body weight and
macrophage inhibitory cytokine-1 during chemotherapy in advanced
gastric cancer: what is their clinical significance? PLoS One.
9:e885532014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pei H, Pu H, Dai M, Bai Y, Chang S, Wang
Z, Cheng N, Li H, Li J, Hu X, et al: Disease burden of gastric
cancer in Jinchang cohort. Zhonghua Liu Xing Bing Xue Za Zhi.
37:316–320. 2016.(In Chinese). PubMed/NCBI
|
|
7
|
Sun PD, Cao H, Zhu JM and Fang XD: Value
of radical dissection with vagus nerve preservation for proximal
gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi. 14:117–119.
2011.(In Chinese). PubMed/NCBI
|
|
8
|
Meng FS, Zhang ZH, Wang YM, Lu L, Zhu JZ
and Ji F: Comparison of endoscopic resection and gastrectomy for
the treatment of early gastric cancer: a meta-analysis. Surg
Endosc. 10:125–126. 2015.
|
|
9
|
Zhang YM, Boerwinkel DF, Qin X, He S, Xue
L, Weusten BL, Dawsey SM, Fleischer DE, Dou LZ, Liu Y, et al: A
randomized trial comparing multiband mucosectomy and cap-assisted
endoscopic resection for endoscopic piecemeal resection of early
squamous neoplasia of the esophagus. Endoscopy. 48:330–338.
2016.PubMed/NCBI
|
|
10
|
Skipworth RJ, Deans DA, Tan BH, Sangster
K, Paterson- Brown S, Brown DA, Hunter M, Breit SN, Ross JA and
Fearon KC: Plasma MIC-1 correlates with systemic inflammation but
is not an independent determinant of nutritional status or survival
in oesophago-gastric cancer. Br J Cancer. 102:665–672. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baek KE, Yoon SR, Kim JT, Kim KS, Kang SH,
Yang Y, Lim JS, Choi I, Nam MS, Yoon M, et al: Upregulation and
secretion of macrophage inhibitory cytokine-1 (MIC-1) in gastric
cancers. Clin Chim Acta. 401:128–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim KK, Lee JJ, Yang Y, You KH and Lee JH:
Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the
transactivation of ErbB2 in human breast and gastric cancer cells.
Carcinogenesis. 29:704–712. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee DH, Yang Y, Lee SJ, Kim KY, Koo TH,
Shin SM, Song KS, Lee YH, Kim YJ, Lee JJ, et al: Macrophage
inhibitory cytokine-1 induces the invasiveness of gastric cancer
cells by up-regulating the urokinase-type plasminogen activator
system. Cancer Res. 63:4648–4655. 2003.PubMed/NCBI
|
|
14
|
Yang H, Filipovic Z, Brown D, Breit SN and
Vassilev LT: Macrophage inhibitory cytokine-1: a novel biomarker
for p53 pathway activation. Mol Cancer Ther. 2:1023–1029.
2003.PubMed/NCBI
|
|
15
|
Pang RP, Zhou JG, Zeng ZR, Li XY, Chen W,
Chen MH and Hu PJ: Celecoxib induces apoptosis in COX-2 deficient
human gastric cancer cells through Akt/GSK3beta/NAG-1 pathway.
Cancer Lett. 251:268–277. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang Y, He Q, Hillman MJ, Rong R and
Sheikh MS: Sulindac sulfide-induced apoptosis involves death
receptor 5 and the caspase 8-dependent pathway in human colon and
prostate cancer cells. Cancer Res. 61:6918–6924. 2001.PubMed/NCBI
|
|
17
|
Yamaguchi K, Lee SH, Eling TE and Baek SJ:
Identification of nonsteroidal anti-inflammatory drug-activated
gene (NAG-1) as a novel downstream target of phosphatidyl inositol
3-kinase/AKT/GSK-3beta pathway. J Biol Chem. 279:49617–49623. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu T, Bauskin AR, Zaunders J, Brown DA,
Pankhurst S, Russell PJ and Breit SN: Macrophage inhibitory
cytokine 1 reduces cell adhesion and induces apoptosis in prostate
cancer cells. Cancer Res. 63:5034–5040. 2003.PubMed/NCBI
|
|
19
|
Macchione E, Epifano O, Stefanini M, Belin
D and Canipari R: Urokinase redistribution from the secreted to the
cell-bound fraction in granulosa cells of rat preovulatory
follicles. Biol Reprod. 62:895–903. 2000. View Article : Google Scholar : PubMed/NCBI
|
